We gratefully acknowledge the comments and contributions of the following in reviewing the manuscript:
B. Blomberg (University of Bergen/Centre for International Health, Norway), R. Day (Ministry of Health/National TB Programme, Indonesia), P. Evans (Global TB Drug Facility), M. Everard (WHO/Essential Drugs and Medicines Policy), J.Gravendeel (Netherlands Leprosy Relief), H.V. Hogerzeil (WHO/Essential Drugs and Medicines Policy), D. Kibuga (WHO/Regional Office for Africa), R.O. Laing (Boston University/School of Public Health, USA), F. Loprang (National TB Consultant to WHO, Indonesia), S. Ottami (WHO/Stop TB), M. Raviglione (WHO/Stop TB), V. Reggi (WHO/Essential Drugs and Medicines Policy), G. Roscigno (Global Alliance for TB Drug Development), L.S. Slamet (Ministry of Health, Indonesia), I. Smith (WHO/Stop TB and Global TB Drug Facility), Y. Tailor (World Bank/Human Development/Operations Policy and Country Services, USA), Y. Uchiyama (WHO/Stop TB), A. Zagorskiy (Management Sciences for Health/Country Programme Coordination).
The first draft of the guide was prepared by S. Phanouvong (WHO/Essential Drugs and Medicines Policy and Stop TB Department), and the cover graphic by T. Moran (WHO/Stop TB Department). Initial layout was done by E. Murray (WHO/Essential Drugs and Medicines Policy).